Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of centrally acting agents such as NK1 receptor antagonists and other bioactive molecules. Its chiral piperidine structure allows for selective interactions in biological systems, making it valuable in the preparation of drugs targeting neurological and psychiatric disorders. The bromomethyl group enables further functionalization through alkylation or cross-coupling reactions, facilitating the construction of complex molecular architectures in medicinal chemistry. Commonly employed in route development for APIs where stereochemistry plays a critical role in efficacy and safety.